Research
CBD Didn't Top Placebo for Behavioral Problems in Kids With Intellectual Disability
The Brief
- A randomized clinical trial in Australia found cannabidiol (CBD) was no better than placebo for severe behavioral problems in children with intellectual disability.
- The result comes from an intention-to-treat analysis, which compares patients by their original randomized group.
- The findings are reported by MedPage Today, dated 2026-11-16.
Why it matters
Families and clinicians considering CBD for severe behavioral problems in children with intellectual disability have trial evidence showing no benefit over placebo in this trial.
Who’s affected
- clinicians treating children with intellectual disability
- families and caregivers of children with severe behavioral problems
- #cbd
- #cannabidiol
- #intellectual disability
- #pediatrics
- #clinical trial
- #behavioral problems
(MedPage Today) -- Cannabidiol (CBD) was no better than placebo for treating severe behavioral problems in kids with intellectual disabilities, a randomized clinical trial in Australia showed. In an intention-to-treat analysis, patients randomized...